Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL302073

CCCCn1cc[n+](C)c1.O=C([O-])C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
HSP90AA1 P07900 2/20 0.58
KMT2A Q03164 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
APAF1 O14727 1/20 0.58
NPC1 O15118 1/20 0.58
PLA2G1B P04054 1/20 0.58
MAPT P10636 1/20 0.58
MAPK1 P28482 1/20 0.58
HTT P42858 1/20 0.58
RAB9A P51151 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
ATG4B Q9Y4P1 1/20 0.58
FDPS P14324 17/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3764708 0.94 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoroacetic Acid SCHEMBL6662106 0.94 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoroacetic Acid SCHEMBL27688970 0.90 SMN1; SMN2 (0.59) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Pivalate SCHEMBL18575129 0.90 MEN1 (0.59) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bicarbonate SCHEMBL5032085 0.89 SMN1; SMN2 (0.67) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL1172730 0.88 MEN1 (0.51) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bicarbonate SCHEMBL2127082 0.88 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Acetic Acid SCHEMBL35016 0.88 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoroacetic Acid SCHEMBL14974451 0.87 SMN1; SMN2 (0.49) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL6570797 0.87 MEN1 (0.50) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120005233-A Tough polyurethane ionic gel based on hard segment reinforcement and preparation method thereof 四川大学 2025-05-16 CN claimed
EP-3470493-B1 COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS PHASE CHANGE ENERGY SOLUTIONS INC (US) 2024-05-15 EP claimed
WO-2024081696-A2 COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2024-04-18 WO claimed
CN-117050023-A Method for preparing 5-fluorocytosine 浙江省化工研究院有限公司 2023-11-14 CN claimed
CN-114130165-B Recyclable ionic gel dehumidifying bag 中国科学院大连化学物理研究所 2023-03-24 CN claimed
CN-114133501-B Preparation method of high-water-vapor adsorption polymer ionic gel 中国科学院大连化学物理研究所 2023-01-24 CN claimed
CN-110560079-B Catalyst for preparing acrylic acid or acrolein and preparation method thereof 浙江新和成股份有限公司 2022-01-25 CN claimed
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY CUSTOMARRAY INC (US) 2021-12-23 US claimed
CN-107847867-B Composite membranes having improved performance and/or durability and methods of use thereof 3M创新有限公司 2021-06-25 CN claimed
US-10907080-B2 Compositions comprising latent heat storage materials and methods of making the same PHASE CHANGE ENERGY SOLUTIONS, INC. (US) 2021-02-02 US claimed
WO-2004052340-A1 MICROPARTICLES PREPARED USING AN IONIC LIQUID NOVARTIS AG (CH) 2004-06-24 WO claimed
US-20040059153-A1 Process for carbonylating alcohols, employing a catalyst based on rhodium or iridium in a non-aqueous ionic liquid, with efficient catalyst recycling INSTITUT FRANCAIS DU PETROLE (FR) 2004-03-25 US claimed
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling INSTITUT FRANCAIS DU PETROLE (FR) 2003-12-04 US claimed
US-20030220191-A1 Catalyst composition for dimerizing, co-dimerizing, oligomerizing and polymerizing olefins INSTITUT FRANCAIS DU PETROLE (FR) 2003-11-27 US claimed
US-6617474-B2 Reacting olefinically unsaturated compound with carbon monoxide and hydrogen in presence of polar phase comprising: a non-aqueous ionic liquid comprising quaternary ammonium and/or a quaternary phosphonium compound and catalyst; adding solvent INSTITUT FRANCAIS DU PETROLE (FR) 2003-09-09 US claimed
US-6579343-B2 Contacting gas with a liquid ionic compound comprising a nitrogen-containing heterocyclic cation UNIVERSITY OF NOTRE DAME DU LAC 2003-06-17 US claimed
US-20020189444-A1 Purification of gas with liquid ionic compounds NATIONAL SCIENCE FOUNDATION 2002-12-19 US claimed
US-20020099243-A1 Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent INSTITUT FRANCAIS DU PETROLE (FR) 2002-07-25 US claimed
US-6410799-B1 LIQUID PHASE HEATING INSTITUT FRANCAIS DU PETROLE (FR) 2002-06-25 US claimed
US-20020035297-A1 Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent INSTITUT FRANCAIS DU PETROLE (FR) 2002-03-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395906-A1 ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY DNMT1, DNASE1, DNPEP MEN1 1771/4885HSP90AA1 3933/4885KMT2A 3944/4885
US-20020099243-A1 Process for the hydroformylation of olefinically unsaturated compounds in a non-aqueous ionic solvent NUDT1, PHOSPHO1, SRSF6 MEN1 3137/4885HSP90AA1 2906/4885KMT2A 2397/4885
US-20020035297-A1 Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent NUDT1, IDH1, HRH4 MEN1 3468/4885HSP90AA1 1482/4885KMT2A 1411/4885
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling NUDT1, AP2S1, SRSF1 MEN1 4317/4885HSP90AA1 3154/4885KMT2A 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.